Gut · 2012 · 132 citations · 30 references
MedicineClinical SciencesImmunologyClinical ImmunologyImmunopathologyMucosal ImmunologyColonic DiseasesGastrointestinal ImmunologyGastrointestinal InflammationGastrointestinal PathologyInflammatory BiomarkersInflammatory Bowel DiseaseAnti-neutrophil Cytoplasmic AntibodiesAnti-neutrophil Cytoplasmic Antibody TestingColonic PathologyGastrointestinal Disease BiomarkersLogistic RegressionMucosal Immunity BiomarkersPositive Predictive ValueSerological Screening
OBJECTIVE: Anti-neutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies (ASCAs) have been detected in the serum of patients with ulcerative colitis (UC) and Crohn's disease (CD) and their unaffected family members. The aim of this study was to establish the value of serological markers as predictors of UC and CD. DESIGN: Individuals who developed CD or UC were identified from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. At recruitment, none of the participants had a diagnosis of CD or UC. For each incident case, two controls were randomly selected matched for centre, date of birth, sex, date of recruitment and time of follow-up. Serum of cases and controls obtained at recruitment were analysed for ASCA IgG, ASCA IgA, perinuclear anti-neutrophil cytoplasmic antibody (pANCA), antibodies against Escherichia coli outer membrane porin C (OmpC) and flagellin CBir1. Conditional logistic regression was used to determine risk of CD and UC. Receiver operating characteristic curves were constructed to test accuracy. RESULTS: A total of 77 individuals were diagnosed with CD and 167 with UC after a mean follow-up of 4.5 (SD 3.2) and 4.4 (SD 3.1) years following blood collection, respectively. Combinations of pANCA, ASCA, anti-CBir1 and anti-OmpC were most accurate in predicting incident CD and UC (area under curve 0.679 and 0.657, respectively). The predictive value of the combination of markers increased when time to diagnosis of CD or UC decreased. CONCLUSION: A panel of serological markers is able to predict development of CD and UC in individuals from a low-risk population.
30
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Fumitaka Hayashi, Kelly D. Smith, Adrian Ozinsky et al. · Nature · 2001 · 3.6K citations
Bacterial flagellin is a dominant antigen in Crohn disease
Michael J. Lodes, Yingzi Cong, Charles O. Elson et al. · Journal of Clinical Investigation · 2004 · 712 citations · Full text